Evidence map›Paper›PMID 30784584›Full record

ArticleCell reports2019

An Acinetobacter baumannii, Zinc-Regulated Peptidase Maintains Cell Wall Integrity during Immune-Mediated Nutrient Sequestration.

Zachery R Lonergan, Brittany L Nairn, Jiefei Wang, Yen-Pang Hsu, Laura E Hesse, William N Beavers, Walter J Chazin, Jonathan C Trinidad, Michael S VanNieuwenhze, David P Giedroc and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Drug-resistantClinical microbiology reviews · 2025
    Pooled it
  2. Review
  3. AnResearch square · 2026
    Article
  4. Article
  5. A periplasmic zinc capture protein enhances the resistance ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Carbapenem-ResistantMicroorganisms · 2025
    Review
  8. Article
  9. Review
  10. Iron-dependent mechanisms inJAC-antimicrobial resistance · 2025
    Review
  11. Article
  12. The interplay betweenInfection and immunity · 2025
    Article
  13. Modelling host-pathogen interactions:Microbiology (Reading, England) · 2025
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zachery R LonerganDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Microbe-Host Interactions Training Program, Vanderbilt University School of Medicine, Nashville, TN, USA.
Brittany L NairnDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jiefei WangDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, USA; Department of Chemistry, Indiana University, Bloomington, IN, USA.
Yen-Pang HsuDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, USA.
Laura E HesseDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Microbe-Host Interactions Training Program, Vanderbilt University School of Medicine, Nashville, TN, USA.
William N BeaversDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Walter J ChazinCenter for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Chemistry, Vanderbilt University, Nashville, TN, USA; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, TN, USA.
Jonathan C TrinidadDepartment of Chemistry, Indiana University, Bloomington, IN, USA; Laboratory for Biological Mass Spectrometry, Department of Chemistry, Indiana University, Bloomington, IN, USA.
Michael S VanNieuwenhzeDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, USA; Department of Chemistry, Indiana University, Bloomington, IN, USA.
David P GiedrocDepartment of Molecular and Cellular Biochemistry, Indiana University, Bloomington, IN, USA; Department of Chemistry, Indiana University, Bloomington, IN, USA.
Eric P SkaarDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: eric.skaar@vumc.org.
Indiana University Bloomington · USVanderbilt University Medical Center · USVanderbilt University · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Host-mediated zinc sequestration during Acinetobacter baumannii infectionR01AI101171 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WALTER J. CHAZIN, DAVID P. GIEDROC · 2013 to 2026
$8.2M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial PathogensR35GM118157 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI DAVID P. GIEDROC · 2016 to 2026
$5.9M
Childhood Infections Research ProgramT32AI095202 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JAMES E CASSAT · 2011 to 2026
$4.2M
Dynamics of bacterial peptidoglycan synthesisR01GM113172 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · PI BRUN, YVES V, VANNIEUWENHZE, MICHAEL S · 2015 to 2018
$3.5M
Elucidating the A. baumannii response to calprotectin-mediated zinc starvationF32AI108192 · NIAID · VANDERBILT UNIVERSITY · PI NAIRN, BRITTANY LYNNE · 2013 to 2014
$102k
Peptidoglycan remodeling during zinc starvation in Acinetobacter baumanniiF31AI136255 · NIAID · VANDERBILT UNIVERSITY · PI LONERGAN, ZACHERY · 2018 to 2020
$65k
NHLBI NIH HHS T32 HL069765NIAID NIH HHS F31 AI136255NIAID NIH HHS F32 AI108192NIAID NIH HHS R01 AI101171NIAID NIH HHS T32 AI095202NIDDK NIH HHS P30 DK058404NIEHS NIH HHS T32 ES007028NIGMS NIH HHS R01 GM113172NIGMS NIH HHS R35 GM118157NIGMS NIH HHS T32 GM008320NIGMS NIH HHS T32 GM065086
6 · The paper itself

Abstract

Acinetobacter baumannii is an important nosocomial pathogen capable of causing wound infections, pneumonia, and bacteremia. During infection, A. baumannii must acquire Zn to survive and colonize the host. Vertebrates have evolved mechanisms to sequester Zn from invading pathogens by a process termed nutritional immunity. One of the most upregulated genes during Zn starvation encodes a putative cell wall-modifying enzyme which we named ZrlA. We found that inactivation of zrlA diminished growth of A. baumannii during Zn starvation. Additionally, this mutant strain displays increased cell envelope permeability, decreased membrane barrier function, and aberrant peptidoglycan muropeptide abundances. This altered envelope increases antibiotic efficacy both in vitro and in an animal model of A. baumannii pneumonia. These results establish ZrlA as a crucial link between nutrient metal uptake and cell envelope homeostasis during A. baumannii pathogenesis, which could be targeted for therapeutic development.

Indexed as

Acinetobacter baumanniiAnimalsAnti-Bacterial AgentsBacterial ProteinsCell WallDrug Resistance, BacterialMaleMetalloendopeptidasesMiceMice, Inbred C57BLPneumonia, BacterialZincAnti-Bacterial AgentsBacterial ProteinsMetalloendopeptidasesZincAcinetobacterantibioticscalprotectininfectionmetalsnutritional immunitypeptidasepeptidoglycanzinc

Identifiers

PMID30784584
PMCPMC6441547
OpenAlexW2917813221

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.